Y-mabs to announce third quarter 2022 financial and operating results on november 7, 2022

New york, nov. 02, 2022 (globe newswire) -- y-mabs therapeutics, inc. (the “company” or “y-mabs”) (nasdaq: ymab) today announced that it will report its financial results for the quarter that ended september 30, 2022, on monday, november 7, 2022, after the close of the u.s. financial markets. the announcement will be followed by a conference call and webcast with the investment community on tuesday, november 8, 2022, at 4:00 p.m. et. participating on the call from y-mabs will be thomas gad, founder, chairman and interim ceo; bo kruse, chief financial officer; sue smith, chief commercial officer and vignesh rajah, chief medical officer.
YMAB Ratings Summary
YMAB Quant Ranking